Table 1. Summary of clinical and histopathologic data on patients with malignant eyelid tumor.
| Parameters | n(%) | Recurrence n(%) | Mean recurrence time (months) |
| Histopathologic type | |||
| BCC | 35(46.7) | 4(11.4) | 74 |
| SGC | 22(29.3) | 3(13.7) | 47 |
| SCC | 7(9.3) | 4(57.1) | 30 |
| MM | 10(13.3) | 6(60.0) | 22 |
| Gender | |||
| Female | 34(45.3) | 6(17.6) | 61 |
| Male | 41(54.7) | 11(26.8) | 55 |
| Age (a) | |||
| ≤65 | 39(52.0) | 10(25.6) | 59 |
| >65 | 36(48.0) | 7(19.4) | 49 |
| Eye | |||
| Right eye | 45(60.0) | 12(26.7) | 45 |
| Left eye | 30(40.0) | 5(16.7) | 75 |
| Location | |||
| Upper lid | 35(46.7) | 7(20.0) | 46 |
| Lower lid | 32(42.7) | 6(18.7) | 68 |
| Canthus | 8(10.7) | 4(50.0) | 22 |
| Medial | 22(29.3) | 4(18.2) | 43 |
| Central | 24(32.0) | 4(16.7) | 72 |
| Lateral | 29(38.7) | 9(31.0) | 47 |
BCC: Basal cell carcinoma; SGC: Sebaceous gland carcinoma; SCC: Squamous cell carcinoma; MM: Malignant melanoma.